Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 23, Issue 1, 2001, Pages 37-39

  Dixit, R K ^a   Chawla, A B ^a   Kumar, N ^a   Garg, S K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Carbamazepine; Omeprazole; Pharmacokinetics

Indexed keywords

CARBAMAZEPINE; OMEPRAZOLE;

ADULT; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG EFFECT; EPILEPSY; HUMAN; MALE; NORMAL HUMAN; SUSTAINED RELEASE PREPARATION;

EID: 0034983922     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2001.23.1.619178     Document Type: Article

References (16)

1. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy a randomized comparative monotherapy trial
2. Comparison of carbamazepine phenobarbital phenytoin primidone in partial and secondary generalized tonic-clonic seizures
3. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clinic seizures in adults
4. Medical management of trigeminal neuralgia
5. Neurogenic pain syndromes and their management
6. Carbamazepine absorption, distribution and excretion
7. Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients
8. Carbamazepine plasma and tissue levels in rat
9. Inhibition of gastric acid secretion by omeprazole in the dogs and rat
10. The relationship between the binding of 2-n-alkylbenzimidazoles to rat hepatic microsomal cytochrome P450 and the inhibition of monooxygenation
11. Stereoselective interaction of omeprazole with warfarin in healthy men
12. Omeprazole inhibits oxidative drug metabolism: Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro
13. Simultaneous HPLC measurement of phenobarbitone, phenytoin and carbamazepine from plasma samples
14. Omeprazole inhibits elimination of diazepam
15. Omeprazole effects on oxidative drug metabolism
16. Inhibition of human liver cytochrome P-450 by omeprazole